⌘K

Login Start Free

Home/Filings/4/0001181431-05-008248

4//SEC Filing

RYNARD CAROLYN 4

Accession 0001181431-05-008248

CIK 0001159036other

View on SEC.gov Company Profile

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 4:27 PM ET

Size

6.8 KB

Accession

0001181431-05-008248

Insider Transaction Report

Form 4

Period: 2005-02-09

HALOZYME THERAPEUTICS INCHTI

Vice President

Transactions

Exercise/Conversion
Common Stock
2005-02-09$0.39/sh+100,000$39,000→ 100,000 total
Exercise/Conversion
Options to Purchase Common Stock
2005-02-09$0.39/sh−100,000$39,000→ 394,240 total
Exercise: $0.39From: 2003-11-11Exp: 2013-11-11→ Common Stock (100,000 underlying)

Documents

1 file

4
rrd67754.xmlPrimary
FORM 4 RYNARD

Issuer

HALOZYME THERAPEUTICS INC

CIK 0001159036

Entity typeother

Related Parties

1

filerCIK 0001284009

Filing Metadata

Form type: 4
Filed: Feb 8, 7:00 PM ET
Accepted: Feb 9, 4:27 PM ET
Size: 6.8 KB

View on SEC.gov